Internal emails discussing adverse event patterns, safety committee meeting minutes, communications with FDA about label changes, and analyses of adverse event database reports all provide key evidence that the company knew about gastroparesis risks before adequately warning patients and doctors
Erguder IB, Ucar A, Ariturk I, et al
The three receptors are GLP-1, GIP, and glucagon
Exercise Patterns Incorporating healthy habits, like daily, light exercise into your routine is important while taking GLP-1 medications
Both sides have recently published a Phase 3 clinical result
Neuen BL, Fletcher RA, Anker SD, Bhatt DL, Butler J, Cherney DZI, Docherty KF, Inzucchi SE, Jardine MJ, Mahaffey KW, McCausland FR, McGuire DK, McMurray JJV, Neal B, Packer M, Patel SM, Perkovic V, Sabatine MS, Sardell RJ, Solomon SD, Vaduganathan M, Wanner C, Wheeler DC, Zannad F, Haynes R, Staplin N, Herrington WG, Heerspink HJL